Skip to main content

Research Repository

Advanced Search

Impact of the iWHELD digital person-centered care program on quality of life, agitation and psychotropic medications in people with dementia living in nursing homes during the COVID-19 pandemic: A randomized controlled trial

Mcdermid, Joanne; Henley, William; Corbett, Anne; Williams, Gareth; Fossey, Jane; Clare, Linda; Fox, Chris; Aarsland, Dag; Khan, Zunera; Soto, Maria; Woodward-Carlton, Barbara; Cook, Esme Moniz; Cummings, Jeffrey; Sweetnam, Adrienne; Chan, Xavier; Lawrence, Megan; Ballard, Clive

Authors

Joanne Mcdermid

William Henley

Anne Corbett

Gareth Williams

Jane Fossey

Linda Clare

Chris Fox

Dag Aarsland

Zunera Khan

Maria Soto

Barbara Woodward-Carlton

Profile image of Esme Moniz-Cook

Professor Esme Moniz-Cook E.D.Moniz-Cook@hull.ac.uk
Emeritus Professor of Clinical Psychology of Ageing and Dementia Care Research / Dementia Research Work Group Lead

Jeffrey Cummings

Adrienne Sweetnam

Xavier Chan

Megan Lawrence

Clive Ballard



Abstract

Introduction: iWHELD is a digital person-centered care program for people with dementia in nursing homes adapted for remote delivery during the COVID-19 pandemic. Methods: A 16-week two-arm cluster-randomized controlled trial in 149 UK nursing homes compared iWHELD with treatment as usual (TAU). Primary outcome was the overall quality of life with secondary outcomes of agitation and psychotropic use. Results: iWHELD conferred benefit to quality of life on the primary (F = 4.3, p = 0.04) and secondary measures of quality of life (F = 6.45, p = 0.01) and reduced psychotropic medication use (χ2 = 4.08, p = 0.04) with no worsening of agitation. Benefit was seen in participants who contracted COVID-19, those with agitation at baseline, and those taking psychotropic medications. Discussion: iWHELD confers benefits to quality of life and key measures of well-being, can be delivered during the challenging conditions of a pandemic, and should be considered for use alongside any emerging pharmacological treatment for neuropsychiatric symptoms. Highlights: iWHELD is the only remote, digital delivery nursing home training programme for dementia care iWHELD improved quality of life in people with dementia and reduced antipsychotic use without worsening of agitation Residents who contracted Covid-19 during the study also experienced benefits from iWHELD iWHELD offers a valuable, pandemic-safe tool for improving dementia care.

Citation

Mcdermid, J., Henley, W., Corbett, A., Williams, G., Fossey, J., Clare, L., …Ballard, C. (in press). Impact of the iWHELD digital person-centered care program on quality of life, agitation and psychotropic medications in people with dementia living in nursing homes during the COVID-19 pandemic: A randomized controlled trial. Alzheimer's & dementia, https://doi.org/10.1002/alz.13582

Journal Article Type Article
Acceptance Date Oct 29, 2023
Online Publication Date Dec 20, 2023
Deposit Date Dec 30, 2023
Publicly Available Date Jan 2, 2024
Journal Alzheimer's and Dementia
Print ISSN 1552-5260
Electronic ISSN 1552-5279
Publisher Elsevier
Peer Reviewed Peer Reviewed
DOI https://doi.org/10.1002/alz.13582
Keywords Agitation; COVID-19; Dementia; Digital; iWHELD; Nursing home; Person-centered care; Psychotropic; Quality of life
Public URL https://hull-repository.worktribe.com/output/4498600

Files

Published article (438 Kb)
PDF

Publisher Licence URL
http://creativecommons.org/licenses/by/4.0

Copyright Statement
© 2023 The Authors. Alzheimer's & Dementia published by Wiley Periodicals LLC on behalf of Alzheimer's Association.

This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.




You might also like



Downloadable Citations